You have 9 free searches left this month | for more free features.

Condition

Paroxysmal Nocturnal Hemoglobinuria (2)

Overall Status

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Apellis Pharmaceuticals, Inc. (1)

NovelMed Therapeutics (1)

Collaborator

Intervention

soliris (2)

nm8074 (1)

pegcetacoplan (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

soliris

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Paroxysmal Nocturnal Hemoglobinuria Trial (NM8074, Soliris)

Not yet recruiting

Paroxysmal Nocturnal Hemoglobinuria

NM8074
Soliris

(no location specified)

Jan 17, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (Pegcetacoplan, Soliris)

Completed

Paroxysmal Nocturnal Hemoglobinuria

Pegcetacoplan
Soliris

Los Angeles, California
+52 more

Mar 1, 2022